qDSA Blood Flow Measurement in Patients Undergoing TAE of the Liver
Recruiting
N/A
Interventional Study
Transarterial Embolism
Transarterial Chemoembolization
Radioembolization
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 20 (estimated)
- Sponsor
- University of Wisconsin, Madison · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this research is to evaluate a new technique, quantitative digital subtraction angiography (qDSA), to measure blood flow during liver embolization procedures. Liver embolization is a way of treating liver tumors by blocking blood flow to it. The qDSA technique could help doctors ensure the blood flow to the tumor is decreased by the right amount by calculating blood flow before, dur…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Give voluntary, written informed consent to participate in this study and willing to comply with study-related evaluation and procedure schedule
Exclusion Criteria:
* Pregnancy or breastfeeding
* Patients with an acute kidney injury or stage IV or V chronic kidney disease (C…
Contacts